Cited by 2,222Cancer Cells and MetastasisCellular Mechanics and InteractionsLymphatic System and Diseases

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, Carl-Henrik, Rubin, Kristofer, Pietras, Kristian, Östman, Arne·2004·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

Many solid tumours show an increased interstitial fluid pressure (IFP), which forms a barrier to transcapillary transport. This barrier is an obstacle in tumour treatment, as it results in inefficient uptake of therapeutic agents. There are a number of factors that contribute to increased IFP in the tumour, such as vessel abnormalities, fibrosis and contraction of the interstitial matrix. Lowering the tumour IFP with specific signal-transduction antagonists might be a useful approach to improving anticancer drug efficacy.

Integrity signals

Registry

Crossref · 10.1038/nrc1456

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,985
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,357
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L. H., Croll, S. D., Glazer, N. L., Holash, J. A., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,314
Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,074
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Bałuk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 987
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D. J., Wain, J. R., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 982

Flagged first, then by citations

Show all 78 references

Research works printed but not linked: 1

Kristensen, C. A. et al. Reduction of interstitial fluid pressure after TNF-α treatment of three human melanoma xenografts. Br. J. Cancer 74, 533–536 (1996). · DOI

Sorted by citations

Items 601–700 of 1,003

Nanoparticle-Mediated Drug Delivery for Treating Melanoma
Mundra, V., Li, W., & Mahato, R. I. (2015) · Nanomedicine · doi:10.2217/nnm.15.111 · Cited by 62
Concurrent anti-vascular therapy and chemotherapy in solid tumors using drug-loaded acoustic nanodroplet vaporization
Ho, Y.-J., & Yeh, C. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.018 · Cited by 64
Breaching the Cancer Fortress
Olson, P., & Hanahan, D. (2009) · Science · doi:10.1126/science.1175940 · Cited by 62
Multiscale Modeling in the Clinic: Drug Design and Development
Clancy, C. E., An, G., Cannon, W. R., Liu, Y., May, E. E., Ortoleva, P., Popel, A. S., Sluka, J. P., Su, J., Vicini, P., et al. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1563-0 · Cited by 62
Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model
Gremonprez, F., Descamps, B., Izmer, A. V., Vanhove, C., Vanhaecke, F., Wever, O. D., & Ceelen, W. P. (2015) · Oncotarget · doi:10.18632/oncotarget.5092 · Cited by 62
Histopathological biomarkers for predicting the tumour accumulation of nanomedicines
May, J., Moss, J. I., Mueller, F., Golombek, S. K., Biancacci, I., Rizzo, L. Y., Elshafei, A. S., Gremse, F., Pola, R., Pechar, M., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01197-4 · Cited by 71
Genetically modified T cells targeting neovasculature efficiently destroy tumor blood vessels, shrink established solid tumors and increase nanoparticle delivery
Fu, X., Rivera, A. M., Tao, L., & Zhang, X. (2013) · International Journal of Cancer · doi:10.1002/ijc.28269 · Cited by 63
Sympathectomy decreases size and invasiveness of tongue cancer in rats
Raju, B., Haug, S. R., Ibrahim, S. O., & Heyeraas, K. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.048 · Cited by 62
Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy
Ferreras, J. M., Citores, L., Iglesias, R., Jiménez, P., & Girbés, T. (2011) · Toxins · doi:10.3390/toxins3050420 · Cited by 63
Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model
Özçelikkale, A., Shin, K., Noe-Kim, V., Elzey, B. D., Dong, Z., Zhang, J., Kim, K., Kwon, I. C., Park, K., & Han, B. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.024 · Cited by 63
Enhanced Therapeutic Efficacy of iRGD-Conjugated Crosslinked Multilayer Liposomes for Drug Delivery
Liu, Y., Ji, M. K., Wong, M. K. K., Joo, K., & Wang, P. (2013) · BioMed Research International · doi:10.1155/2013/378380 · Cited by 61
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
Geretti, E., Leonard, S. C., Dumont, N., Lee, H., Zheng, J., Souza, R. D., Gaddy, D. F., Espelin, C. W., Jaffray, D. A., Moyo, V. M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0314 · Cited by 62
The Penetrated Delivery of Drug and Energy to Tumors by Lipo-Graphene Nanosponges for Photolytic Therapy
Su, Y., Chen, K., Sheu, Y.-C., Sung, S.-Y., Hsu, R., Chiang, C., & Hu, S. (2016) · ACS Nano · doi:10.1021/acsnano.6b04414 · Cited by 61
Compressive Remodeling Alters Fluid Transport Properties of Collagen Networks – Implications for Tumor Growth
Ferruzzi, J., Sun, M., Gkousioudi, A., Pilvar, A., Roblyer, D. M., Zhang, Y., & Zaman, M. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-50268-z · Cited by 60
Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management
Allemailem, K. S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s338272 · Cited by 61
Lipopeptide liposomes-loaded hydrogel for multistage transdermal chemotherapy of melanoma
Ni, Y., Zhao, W., Cheng, W., Deng, C., Ying, Z., Li, L., Wang, X., Sun, C., Tu, J., & Jiang, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.014 · Cited by 61
Orange-derived extracellular vesicles nanodrugs for efficient treatment of ovarian cancer assisted by transcytosis effect
Long, F., Pan, Y., Li, J., Sha, S., Shi, X., Guo, H., Huang, C., Xiao, Q., Fan, C., Zhang, X., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.04.006 · Cited by 62
Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier
Xie, Y., Yang, F., He, L., Huang, H., Chao, M., Cao, H., Hu, Y., Fan, Z., Zhai, Y., Zhao, W., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.07.026 · Cited by 63
Collective migration of cancer‐associated fibroblasts is enhanced by overexpression of tight junction‐associated proteins claudin‐11 and occludin
Karagiannis, G. S., Schaeffer, D. F., Cho, C.-K. J., Musrap, N., Saraon, P., Batruch, I., Grin, A., Mitrovic, B., Kirsch, R., Riddell, R. H., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.10.008 · Cited by 61
Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases
Heldin, C. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9484-2 · Cited by 64
Self-citation
iRGD-Conjugated DSPE-PEG2000 Nanomicelles for Targeted Delivery of Salinomycin for Treatment of Both Liver Cancer Cells Cancer Stem Cells
Mao, X.-L., Liu, J., Gong, Z., Zhang, H., Lü, Y., Zou, H. L., Yu, Y., Chen, Y., Sun, Z., Li, W., et al. (2015) · Nanomedicine · doi:10.2217/nnm.15.106 · Cited by 61
Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
Lohiya, V., Aragon‐Ching, J. B., & Sonpavde, G. (2016) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s34535 · Cited by 60
Active Microneedle Administration of Plant Virus Nanoparticles for Cancer In Situ Vaccination Improves Immunotherapeutic Efficacy
Boone, C. E., Wang, C., Lopez‐Ramirez, M. A., Beiss, V., Shukla, S., Chariou, P. L., Kupor, D., Rueda, R. D. Z., Wang, J., & Steinmetz, N. F. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01506 · Cited by 61
Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment
Lee, S. W. L., Seager, R. J., Litvak, F., Spill, F., Sieow, J. L., Leong, P. H., Kumar, D., Tan, A. S. M., Wong, S. C., Adriani, G., et al. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa007 · Cited by 60
RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer
Li, F., Zhao, Y., Mao, C., Kong, Y., & Ming, X. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00321 · Cited by 60
Tumor microenvironment and nanotherapeutics: intruding the tumor fort
Kiran, A. V. V. V. R., Kumari, G. K., Krishnamurthy, P. T., & Khaydarov, R. R. (2021) · Biomaterials Science · doi:10.1039/d1bm01127h · Cited by 61
Human Solid Tumors and Clinical Relevance of The Enhanced Permeation and Retention Effect: A ‘Golden Gate’ for Nanomedicine in Preclinical Studies?
Gawali, P., Saraswat, A. L., Bhide, S., Gupta, S., & Patel, K. R. (2023) · Nanomedicine · doi:10.2217/nnm-2022-0257 · Cited by 63
The role of vasculature and angiogenesis in respiratory diseases
Ackermann, M., Werlein, C., Plucinski, E. K., Leypold, S., Kühnel, M., Verleden, S. E., Khalil, H. A., Länger, F. P., Welte, T., Mentzer, S. J., et al. (2024) · Angiogenesis · doi:10.1007/s10456-024-09910-2 · Cited by 71
Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments
Kennedy, P. R., Arvindam, U. S., Phung, S. K., Ettestad, B., Feng, X., Li, Y., Kile, Q. M., Hinderlie, P., Khaw, M. J., Huang, R., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn1849 · Cited by 62
Advances in targeted therapy for tumor with nanocarriers: A review
Cheng, H., Liao, J., Ma, Y., Sarwar, M. T., & Yang, H. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101583 · Cited by 67
Current trends in mathematical modeling of tumor–microenvironment interactions: a survey of tools and applications
Rejniak, K. A., & McCawley, L. J. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009230 · Cited by 62
Associations between Radiocurability and Interstitial Fluid Pressure in Human Tumor Xenografts without Hypoxic Tissue
Rofstad, E. K., Ruud, E. M., Mathiesen, B. S., & Galappathi, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2718 · Cited by 60
Pathophysiology of Solid Tumors
Vaupel, P. W. (2009) · Medical radiology · doi:10.1007/978-3-540-74386-6_4 · Cited by 59
Treatment of Malignant Brain Tumor by Tumor‐Triggered Programmed Wormlike Micelles with Precise Targeting and Deep Penetration
Zeng, L., Zou, L., Yu, H., He, X., Cao, H., Zhang, Z., Yin, Q., Zhang, P., Gu, W., Chen, L., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600642 · Cited by 60
Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer
Chua, C. Y. X., Jain, P., Šušnjar, A., Rhudy, J. R., Folci, M., Ballerini, A., Gilbert, A. L., Singh, S., Bruno, G., Filgueira, C. S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.035 · Cited by 61
Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides
Ming, X., Carver, K. A., & Wu, L. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.066 · Cited by 60
The tumor organismal environment: Role in tumor development and cancer immunotherapy
Dieterich, L. C., & Bikfalvi, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.021 · Cited by 61
Novel drug delivery systems: Insight into self-powered and nano-enabled drug delivery systems
Ewii, U. E., Onugwu, A. L., Nwokpor, V. C., Akpaso, I.-A., Ogbulie, T. E., Aharanwa, B., Chijioke, C., Verla, N., Iheme, C. I., Ujowundu, C. O., et al. (2024) · Nano TransMed · doi:10.1016/j.ntm.2024.100042 · Cited by 61
Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It
Mendoza, E. N., Ciriolo, M. R., & Ciccarone, F. (2025) · Antioxidants · doi:10.3390/antiox14010094 · Cited by 65
Enhancing solid tumor therapy with sequential delivery of dexamethasone and docetaxel engineered in a single carrier to overcome stromal resistance to drug delivery
Zhang, L., Su, H., Liu, Y., Pang, N., Li, J., & Qi, X. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.004 · Cited by 60
Significant Radiation Enhancement Effects by Gold Nanoparticles in Combination with Cisplatin in Triple Negative Breast Cancer Cells and Tumor Xenografts
Cui, L., Her, S., Dunne, M., Borst, G. R., De Souza, R., Bristow, R. G., Jaffray, D. A., & Allen, C. (2017) · Radiation Research · doi:10.1667/rr14578.1 · Cited by 58
Modulating tumor physical microenvironment for fueling CAR-T cell therapy
Luo, Z. Y., Yao, X., Li, M., Fang, D., Fei, Y., Cheng, Z., Xu, Y., & Zhu, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114301 · Cited by 59
Curvature-mediated rapid extravasation and penetration of nanoparticles against interstitial fluid pressure for improved drug delivery
Jiang, X., Xu, S., Miao, Y., Huang, K., Wang, B., Ding, B., Zhang, Z., Zhao, Z., Zhang, X., Shi, X., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319880121 · Cited by 57
High Interstitial Fluid Pressure Is Associated with Low Tumour Penetration of Diagnostic Monoclonal Antibodies Applied for Molecular Imaging Purposes
Heine, M., Freund, B., Nielsen, P., Jung, C., Reimer, R., Hohenberg, H., Zangemeister‐Wittke, U., Wester, H., Lüers, G. H., & Schumacher, U. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036258 · Cited by 57
Multifunctional Albumin Nanoparticles As Combination Drug Carriers for Intra‐Tumoral Chemotherapy
Cui, M., Naczynski, D. J., Zevon, M., Griffith, C. K., Sheihet, L., Poventud‐Fuentes, I., Chen, S., Roth, C. M., & Moghe, P. V. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201200467 · Cited by 58
Multifunctional Liposomes for Image‐Guided Intratumoral Chemo‐Phototherapy
Miranda, D., Carter, K., Luo, D., Shao, S., Geng, J., Li, C., Chitgupi, U., Turowski, S. G., Li, N., Atilla‐Gokcumen, G. E., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700253 · Cited by 58
Organic/inorganic nanohybrids rejuvenate photodynamic cancer therapy
Liang, C., Zhang, X., Wang, Z., Wang, W., Yang, M., & Dong, X. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00098a · Cited by 58
iRGD‐Liposomes Enhance Tumor Delivery and Therapeutic Efficacy of Antisense Oligonucleotide Drugs against Primary Prostate Cancer and Bone Metastasis
Guan, J., Guo, H., Tang, T., Wang, Y., Wei, Y., Seth, P. P., Li, Y., Dehm, S. M., Ruoslahti, E. I., & Pang, H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100478 · Cited by 58
Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
Chuangchot, N., Jamjuntra, P., Yangngam, S., Luangwattananun, P., Thongchot, S., Junking, M., Thuwajit, P., Yenchitsomanus, P., & Thuwajit, C. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01684-7 · Cited by 58
Breaking biological barriers: Engineering polymeric nanoparticles for cancer therapy
Austria, E. S., Jr., Bilek, M., Varamini, P., & Akhavan, B. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102552 · Cited by 63
Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery
Li, Y., Sun, H., Cao, D. S., Guo, Y., Wu, D., Yang, M., Wang, H., Shao, X., Li, Y., & Liang, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s497510 · Cited by 60
Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma
Salnikov, A. V., Roswall, P., Sundberg, C., Gardner, H., Heldin, N., & Rubin, K. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700252 · Cited by 58
Self-citation
Fc-mOX40L Fusion Protein Produces Complete Remission and Enhanced Survival in 2 Murine Tumor Models
Sadun, R. E., Hsu, W.-E., Zhang, N., Nien, Y.-C., Bergfeld, S. A., Sabzevari, H., Lutsiak, M. E. C., Khawli, L. A., Hu, P., & Epstein, A. L. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31816a88e0 · Cited by 57
Edema and fluid dynamics in connective tissue remodelling
Reed, R. K., Lidén, Å., & Rubin, K. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.06.023 · Cited by 57
Self-citation
Understanding nano-bio interactions to improve nanocarriers for drug delivery
Pearson, R. M., Hsu, H.-J., Bugno, J., & Hong, S. (2014) · MRS Bulletin · doi:10.1557/mrs.2014.9 · Cited by 57
Potent Retro-Inverso d -Peptide for Simultaneous Targeting of Angiogenic Blood Vasculature and Tumor Cells
Li, Y., Yang, L., Wagner, E., Xie, C., Lu, W., Zhu, J., Shen, J., Wang, J., & Liu, M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300537z · Cited by 57
Apparent Diffusion Coefficient in Estrogen Receptor–Positive Invasive Ductal Breast Carcinoma: Correlations with Tumor-Stroma Ratio
Ko, E. S., Han, B., Kim, R. B., Cho, E. Y., Ahn, S., Nam, S. J., Ko, E. Y., Shin, J. H., & Hahn, S. Y. (2013) · Radiology · doi:10.1148/radiol.13131073 · Cited by 57
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective
Ahmad, J., Akhter, S., Khan, M. A., Wahajuddin, M., Greig, N. H., Kamal, M. A., Midoux, P., & Pichon, C. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160617112111 · Cited by 57
Dynamics of nanoparticle diffusion and uptake in three-dimensional cell cultures
Belli, V., Guarnieri, D., Biondi, M., Sala, F. D., & Netti, P. A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.09.046 · Cited by 57
Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts
Luo, T., Sun, J., Zhu, S., He, J., Hao, L., Xiao, L., Zhu, Y., Wang, Q., Pan, X. H., Wang, Z., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.032 · Cited by 57
A light-driven dual-nanotransformer with deep tumor penetration for efficient chemo-immunotherapy
Peng, J., Chen, F., Liu, Y., Zhang, F., Cao, L., You, Q., Yang, D., Chang, Z., Ge, M., Li, L., et al. (2022) · Theranostics · doi:10.7150/thno.68756 · Cited by 58
Role of Convective Flow in Carmustine Delivery to a Brain Tumor
Arifin, D. Y., Lee, K. Y. T., Wang, C., & Smith, K. A. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9945-8 · Cited by 56
The Pharmacokinetic/Pharmacodynamic Pipeline: Translating Anticancer Drug Pharmacology to the Clinic
Zhou, Q. S., & Gallo, J. M. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9253-1 · Cited by 56
Programming the lifestyles of engineered bacteria for cancer therapy
Fu, S., Zhang, R., Gao, Y., Xiong, J., Li, Y., Pu, L., Xia, A., & Jin, F. (2023) · National Science Review · doi:10.1093/nsr/nwad031 · Cited by 55
Development of drug loaded nanoparticles for tumor targeting. Part 2: Enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models
El‐Dakdouki, M. H., Puré, E., & Huang, X. (2013) · Nanoscale · doi:10.1039/c3nr90022c · Cited by 55
Polymer-drug conjugates: recent progress on administration routes
Pang, X., Yang, X., & Zhai, G. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.912779 · Cited by 55
Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages
Park, S., Kang, S., Chen, X., Kim, E. J., Kim, J., Kim, N., Kim, J., & Jin, M. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.004 · Cited by 55
Multifaceted Transport Characteristics of Nanomedicine: Needs for Characterization in Dynamic Environment
Özçelikkale, A., Ghosh, S., & Han, B. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005947 · Cited by 55
Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients
Halvorsen, A. R., Kristensen, G. B., Embleton-Thirsk, A., Adusei, C., Barretina-Ginesta, M. P., Beale, P. J., & Helland, Å. (2017) · Disease Markers · doi:10.1155/2017/3098542 · Cited by 57
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure
Libutti, S. K., Tamarkin, L., & Nilubol, N. (2018) · Oncotarget · doi:10.18632/oncotarget.26267 · Cited by 55
Human Organ‐Specific 3D Cancer Models Produced by the Stromal Self‐Assembly Method of Tissue Engineering for the Study of Solid Tumors
Roy, V., Magne, B., Vaillancourt-Audet, M., Blais, M., Chabaud, S., Grammond, E., Piquet, L., Fradette, J., Laverdière, I., Moulin, V. J., et al. (2020) · BioMed Research International · doi:10.1155/2020/6051210 · Cited by 57
Azo-inserted responsive hybrid liposomes for hypoxia-specific drug delivery
Long, M., Lu, A., Lü, M., Weng, L., Chen, Q., Zhu, L., & Chen, Z. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.07.061 · Cited by 54
Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancer
Mohammad-Hadi, M., Nesbitt, H., Masood, H., Sciscione, F., Patel, S., Ramesh, B. S., Emberton, M., Callan, J. F., MacRobert, A. J., McHale, A. P., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.040 · Cited by 54
Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular Carcinoma
Barbier, C. E., Heindryckx, F., & Lennernäs, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313051 · Cited by 53
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft
Tan, G., Kasuya, H., Şahin, T. T., Yamamura, K., Wu, Z., Koide, Y., Hotta, Y., Shikano, T., Yamada, S., Kanzaki, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29163 · Cited by 54
Dose Dependence of Intratumoral Perivascular Distribution of Monoclonal Antibodies
Rhoden, J. J., & Wittrup, K. D. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22801 · Cited by 54
Tumor perfusion imaging predicts the intra-tumoral accumulation of liposomes
Stapleton, S., Allen, C. J., Pintilie, M., & Jaffray, D. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.296 · Cited by 55
Microfluidic modeling of the biophysical microenvironment in tumor cell invasion
Huang, Y., Segall, J. E., & Wu, M. (2017) · Lab on a Chip · doi:10.1039/c7lc00623c · Cited by 58
Design of an Amphiphilic iRGD Peptide and Self-Assembling Nanovesicles for Improving Tumor Accumulation and Penetration and the Photodynamic Efficacy of the Photosensitizer
Jiang, Y., Pang, X., Liu, R., Xiao, Q., Wang, P., Leung, A. W., Luan, Y., & Xu, C. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11699 · Cited by 54
Platelet-Derived Growth Factor–Mediated Gliomagenesis and Brain Tumor Recruitment
Fomchenko, E. I., & Holland, E. C. (2007) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2006.10.006 · Cited by 53
Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip
Han, B., Qu, C., Park, K., Konieczny, S. F., & Korc, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.003 · Cited by 53
pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells
Bersani, S., Vila-Caballer, M., Brazzale, C., Barattin, M., & Salmaso, S. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.08.005 · Cited by 53
A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression
Norton, K., Wininger, M., Bhanot, G., Ganesan, S., Barnard, N., & Shinbrot, T. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.11.024 · Cited by 54
Subharmonic aided pressure estimation for monitoring interstitial fluid pressure in tumours – In vitro and in vivo proof of concept
Halldorsdottir, V. G., Dave, J. K., Eisenbrey, J. R., Machado, P., Zhao, H., Liu, J., Merton, D. A., & Forsberg, F. (2014) · Ultrasonics · doi:10.1016/j.ultras.2014.04.022 · Cited by 53
Antibody Drug Conjugates: Preclinical Considerations
Bornstein, G. G. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9738-4 · Cited by 55
Hypoxia Responsive Drug Delivery Systems in Tumor Therapy
Alimoradi, H., Matikonda, S. S., Gamble, A. B., Giles, G. I., & Greish, K. F. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160217130049 · Cited by 53
Retro-Inverso CendR Peptide-Mediated Polyethyleneimine for Intracranial Glioblastoma-Targeting Gene Therapy
Wang, J., Yang, L., Xie, C., Lu, W., Wagner, E., Xie, Z., Gao, J., Zhang, X., Yan, Z., & Liu, M. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400552t · Cited by 53
Characterization of Cell-Type-Specific Drug Transport and Resistance of Breast Cancers Using Tumor-Microenvironment-on-Chip
Shin, K., Klosterhoff, B. S., & Han, B. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00131 · Cited by 53
Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience
Nam, K., Eisenbrey, J. R., Stanczak, M., Sridharan, A. N., Berger, A. C., Avery, T. P., Palazzo, J., & Forsberg, F. (2017) · Radiology · doi:10.1148/radiol.2017161683 · Cited by 53
“Cluster Bomb” Based on Redox-Responsive Carbon Dot Nanoclusters Coated with Cell Membranes for Enhanced Tumor Theranostics
Guo, Y., Fan, Y., Li, G., Wang, Z., Shi, X., & Shen, M. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c15282 · Cited by 53
Model‐based and model‐free parametric analysis of breast dynamic‐contrast‐enhanced MRI
Eyal, E., & Degani, H. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1221 · Cited by 53
The functional cross talk between cancer cells and cancer associated fibroblasts from a cancer mechanics perspective
Ansardamavandi, A., & Tafazzoli‐Shadpour, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119103 · Cited by 53
Molecular Ultrasound Imaging of Early Vascular Response in Prostate Tumors Irradiated with Carbon Ions
Palmowski, M., Peschke, P., Huppert, J., Hauff, P., Reinhardt, M., Mäurer, M., Karger, C. P., Scholz, M., Semmler, W., Huber, P. E., et al. (2009) · Neoplasia · doi:10.1593/neo.09540 · Cited by 52
Antibody-Based Vascular Tumor Targeting
Schliemann, C., & Neri, D. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_12 · Cited by 52
A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors
Hauert, S., Berman, S., Nagpal, R., & Bhatia, S. N. (2013) · Nano Today · doi:10.1016/j.nantod.2013.11.001 · Cited by 52
Zwitterionic Nanoparticles Constructed with Well-Defined Reduction-Responsive Shell and pH-Sensitive Core for “Spatiotemporally Pinpointed” Drug Delivery
Huang, P., Liu, J., Wang, W., Li, C., Zhou, J., Wang, X., Deng, L., Kong, D., Liu, J., & Dong, A. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am503974y · Cited by 52
Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles
Sakurai, Y., Hada, T., Yamamoto, S., Kato, A., Mizumura, W., & Harashima, H. (2016) · Molecular Therapy · doi:10.1038/mt.2016.178 · Cited by 53
Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors
Wang, Z., Wu, Z., Liu, J., & Zhang, W. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1420051 · Cited by 54
Underlying mechanisms and drug intervention strategies for the tumour microenvironment
Li, H., Zhou, L., Zhou, J., Li, Q., & Ji, Q. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01893-y · Cited by 51
A hybrid membrane coating nanodrug system against gastric cancer via the VEGFR2/STAT3 signaling pathway
Long, Y., Wang, Z., Fan, J., Yuan, L., Tong, C., Zhao, Y., & Liu, B. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00029b · Cited by 51

Authors: Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A.
Affiliations: Ludwig Cancer Research (SE)
Uppsala University (SE)
University of California, San Francisco (US)
Karolinska Institutet (SE)
Corresponding author: Heldin, Carl-Henrik
ORCID: Heldin, Carl-Henrik
Rubin, Kristofer
Pietras, Kristian
Östman, Arne
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-10
Volume: 4
Issue: 10
Pages: 806-813
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1456
OpenAlex: W2028156849
Cited by: 2,222
References: 78
Citations by year: 2026: 121 · 2025: 110 · 2024: 118 · 2023: 119 · 2022: 163 · 2021: 158 · 2020: 158 · 2019: 123 · 2018: 123 · 2017: 135 · 2016: 133 · 2015: 110 · 2014: 117 · 2013: 124 · 2012: 87
FWCI: 3.19
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: Cancerfonden
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords: interstitial fluid pressure, solid tumors, tumor microenvironment, tumor fibrosis, anticancer drug delivery, tumor hypoxia
MeSH terms: Alprostadil, Animals, Antineoplastic Agents, Biological Transport, Bradykinin, Humans, Hyaluronoglucosaminidase, Hydrostatic Pressure, Neoplasms, Niacinamide, Platelet-Derived Growth Factor, Tumor Necrosis Factor-alpha, Signal Transduction, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Extracellular Fluid, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks